MetaVisorby Tal Gavoli
MetaVisor is a health information platform founded in 2012 (launched 2013) that personalizes medical research and clinical trial information for patients based on their specific condition and treatment stage. The company operates on a dual revenue model: licensing technology to healthcare organizations and partners (like the Leukemia and Lymphoma Society), and being paid by biopharma companies to identify and engage patients for clinical trials. With 130,000 subscribers across 129 countries and a team of 7 full-time staff plus ~35 part-time contributors, MetaVisor is on track for profitability within 12 months of their upcoming $1-5M fundraise.
SaaSpartnershipssubscriptionvia Nathan Latka Podcast